MENU
TCRX
AS OF
Dec 24 closing price
Price
$1.04
Change
+$0.13 (+14.29%)
Capitalization
59.02M
76 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
TCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TScan Therapeutics (TCRX) Ownership - Who owns TScan Therapeutics?

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
59.02M
P/E Ratio
N/A
Total Cash
184.45M
Projected Growth
N/A
Total Debt
95.62M
Revenue
8.42M
Risk (Beta)
1.72
Dividend Yield
N/A
Total Cash/Share
3.25
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price

Fundamentals

TCRX
Capitalization
59M
P/E Ratio
N/A
Risk (Beta)
1.72
Dividend Yield
N/A
Total Cash
184M
Total Cash/Share
3.25
Total Debt
95.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
8.42M
ROE
N/A
Book Value
144M
P/B Ratio
0.41
Cash Flow
N/A
Earnings
-1.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
6.44
Current Revenue Per Employee
11957.14
Dividends Per Share - Security
N/A
EBITDA
-136.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.73
Shares Held By Institutions
70.1M
Shares Outstanding - Current
56.7M
Total Liabilities
118M
Total Volume MTD
N/A
Value
1
Gain YTD
-70.043
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TCRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TCRX showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for TCRX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com